Physician profile
David C Bloom
NPI 1215996038
$2,137.58
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $450 · 2020: $794 · 2021: $639 · 2022: $147 · 2023: $108.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $108.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $107.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $551.15 | 2019-2021 | |
| Intersect Ent, INC. | $385.56 | 2019-2022 | |
| Acclarent, INC | $295.91 | 2019-2021 | |
| Kaleo, INC. | $205.22 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $130.88 | 2020-2022 | |
| Aerin Medical INC. | $129.76 | 2020 | |
| Alk-Abello, INC | $102.85 | 2019-2020 | |
| Medtronic, INC. | $77.44 | 2023 | Nuvent |
| Genzyme Corporation | $73.12 | 2021-2023 | |
| Glaxosmithkline, LLC. | $63.55 | 2021-2022 | |
| Smith+Nephew, INC. | $50.90 | 2019-2020 | |
| Med-El Corporation | $21.25 | 2020 | |
| Stryker Corporation | $18.62 | 2019 | |
| Novartis Pharmaceuticals Corporation | $17.86 | 2021 | |
| Medtronic USA, INC. | $13.51 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Bloom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.